CD2 is a dominant target for allogeneic responses

American Journal of Transplantation

Volumn 2, Issue 7, 2002, Pages 618-626

  Bai, Yalai ^a   Fu, Shuang ^a   Honig, Shaun ^a   Wang, Yinong ^a   Qin, Lihui ^a   Chen, Dan ^a   Bromberg, Jonathan S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

2B4; CD2; CD244; CD48; T cell receptors; Tolerance

Indexed keywords

CD2 ANTIGEN; LIGAND;

ALLOGRAFT; ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL INTERACTION; CELL PROLIFERATION; CYTOKINE RELEASE; GENE CLUSTER; GRAFT SURVIVAL; IMMUNE RESPONSE; MOUSE; MULTIGENE FAMILY; NATURAL KILLER CELL; NONHUMAN; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ANIMALS; ANTIGENS, CD2; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; RATS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036705293     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20706.x     Document Type: Article

References (29)

1. Qin L, Chavin KD, Lin J, Yagita H, Bromberg JS. Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival. J Exp Med 1994; 179: 341-346.
2. Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992; 255: 1125-1127.
3. Lin J, Chavin KD, Qin L, Ding Y, Bromberg JS. Anti-CD2 monoclonal antibody-induced receptor changes. II. Interaction of CD2 and CD3. Cell Immunol 1996; 167: 249-258.
4. Chang HC, Moingeon P, Lopez P, Krasnow H, Stebbins C, Reinherz EL. Dissection of the human CD2 intracellular domain. Identification of a segment required for signal transduction and interleukin 2 production. J Exp Med 1989; 169: 2073-2083.
5. Danielian S, Fagard R, Alcover A, Acuto O, Fischer S. The tyrosine kinase activity of p56-ck is increased in human T cells activated via CD2. Eur J Immunol 1991; 21: 1967-1970,
6. Marie-Cardine A, Fischer S, Gorvel JP, Maridonneau-Parini I. Recruitment of activated p56-ck on endosomes of CD2-triggered T cells, colocalization with ZAP-70. J Biol Chem 1996; 271: 20 734-20 739.
7. Boussiotis VA, Freeman GJ, Griffin JD, Gray GS, Gribben JG, Nadler LM. CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. J Exp Med 1994; 180: 1665-1673.
8. Davis SJ, van der Merwe PA.The structure and ligand interactions of CD2: implications for T-cell function. Immunol Today 1996; 17: 177-187.
9. Brown MH, Boles K, van der Merwe PA, Kumar V, Mathew PA, Barclay AN. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 1998; 188: 2083-2090.
10. Garni-Wagner BA, Purohit A, Mathew PA, Bennett M, Kumar V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J Immunol 1993; 151: 60-70.
11. Mathew PA, Garni-Wagner BA, Land K et al. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J Immunol 1993; 151: 5328-5337.
12. Schuhmachers G, Ariizumi K, Mathew PA, Bennett M, Kumar V, Takashima A. 2B4, a new member of the immunoglobulin gene superfamily, is expressed on murine dendritic epidermal T cells and plays a functional role in their killing of skin tumors. J Invest Dermatol 1995; 105: 592-596.
13. Schuhmachers G, Ariizumi K, Mathew PA, Bennett M, Kumar V, Takashima A. Activation of murine epidermal gamma delta T cells through surface 2B4. Eur J Immunol 1995; 25: 1117-1120.
14. Valiante NM, Trinchieri G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J Exp Med 1993; 178: 1397-1406.
15. Kubin MZ, Parshley DL, Din W et al. Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48. Eur J Immunol 1999; 29: 3466-3477.
16. Nakajima H, Cella M, Langen H, Friedlein A, Colonna M. Activating interactions in human NK cell recognition the role of 2B4-CD48. Eur J Immunol 1999; 29: 1676-1683.
17. Killeen N, Stuart SG, Littman D. Development and function of T cells in mice with a disrupted CD2 gene. EMBO J 1992; 11: 4329-4336.
18. Gonzalez-Cabrero J, Wise CJ, Latchman Y, Freeman GJ, Sharpe AH, Reiser H. CD48-deficient mice have a pronounced defect in CD4(+) T cell activation. Proc Natl Acad Sci USA 1999; 96: 1019-1023.
19. Kato K, Koyanagi M, Okada H et al. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J Exp Med 1992; 176: 1241-1249.
20. Chavin KD, Qin L, Lin J, Kaplan AJ, Bromberg JS. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects. Transplantation 1993; 55: 901-908.
21. Chavin KD, Qin L, Lin J et al. Anti-CD48 (murine CD2 ligand) mAbs suppress cell mediated immunity in vivo. Int Immunol 1994; 6: 701-709.
22. Boles KS, Stepp SE, Bennett M, Kumar V, Mathew PA. 2B4 (CD244) and CSI. novel members of the CD2 subset of the immunoglovulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunol Rev 2001; 181: 234-249.
23. Bromberg JS, Chavin KD, Altevogt P et al. Anti-CD2 monoclonal antibodies alter cell mediated immunity in vivo. Transplantation 1991; 51: 219-225.
24. Punch JD, Lin J, Bluestone J, Bromberg JS CD2 and CD3 receptor-mediated tolerance: constraints on T cell activation. Transplantation 1999; 67: 741-748.
25. Ding Y, Qin L, Yang Q et al. A novel murine model for the assessment of human CD2-related reagents in vivo. J Immunol 1996; 157: 1863-1869.
26. Murphy WJ, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J Exp Med 1987; 165: 1212-1217.
27. Tangye SG, Lazetic S, Woollatt E, Sutherland GR, Lanier LL, Phillips JH. Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol 1999; 162: 6981-6985.
28. Kambayashi T, Assarsson E, Chambers BJ, Ljunggren HG. Regulation of CD8+ T cell proliferation by 2B4/CD48 interactions. J Immunol 2001; 167: 6706-6710.
29. Chavin KD, Qin L, Yon R, Lin J, Yagita H, Bromberg JS. Anti-CD2 monoclonal antibodies suppress cytotoxic lymphocyte activity by the generation of TH2 suppressor cells and receptor blockade. J Immunol 1994; 152: 3729-3739.